CooperCompanies Q3: $272M Litigation Charge, $307M Tax Benefit, Buyback Expanded to $3B
COO is trading near its 52-week low of $58.89 (8.6% below the low) on elevated volume (3.8× avg).
Summary
CooperCompanies' Q3 10-Q details a $272M litigation charge from the LifeGlobal recall, a $307M UK tax benefit, and a $1B buyback expansion to $3B total authorization.
Key Events · Earnings and Guidance · COO
-
LifeGlobal Litigation: $272M Net Charge
CooperSurgical recorded $272.0M net litigation expense for the nine months ended July 31, 2026, consisting of $325.8M accrued liability partially offset by $53.8M insurance recoveries. In August 2026, $306.8M was paid to plaintiffs to settle substantially all claims.
-
UK Tax Examination: $307.2M Benefit
A favorable completion of the UK tax authority examination in June 2026 released a $307.2M uncertain tax position reserve, recognized as a discrete income tax benefit in Q3.
-
Buyback Authorization Expanded to $3B
The board approved a $1.0B increase to the 2012 Share Repurchase Program in September 2026, raising total authorization to $3.0B with approximately $1.5B remaining. Q3 repurchases totaled 4.9M shares at $69.16 average price.
-
CooperSurgical Operating Loss: $157.1M
CooperSurgical swung to a $157.1M nine-month operating loss from $39.7M operating income a year ago, driven by the litigation charge. CooperVision operating income rose 10% to $631.3M.
Analysis · COO · Industrial Applications And Services
The 10-Q reveals the full financial picture behind the Q3 earnings release. CooperSurgical swung to a $157.1M nine-month operating loss driven by a $272.0M net litigation charge from the LifeGlobal embryo culture media recall — a material liability that was settled in August 2026 with $306.8M paid to plaintiffs. Offsetting this, a favorable UK tax examination released a $307.2M uncertain tax position reserve, producing a one-time tax benefit. The board also expanded the buyback authorization to $3B, with $1.5B remaining. The stock trades near its 52-week low at $53.85, suggesting the market has not fully digested the litigation resolution and capital return commitment.
How filings like this one have moved
In the 30 days to Sep 9, 2026, 30% of the 1972 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.02%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, COO was trading at $53.85 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $12.4B. The 52-week trading range was $58.89 to $89.83. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.